₹210.20
+2.05 (+0.98%)
As of 27 Sept 2026, Piramal Pharma Ltd share price is ₹210.20. The stock opened at ₹210.20 and had closed at ₹208.15 the previous day. Over the last 52 weeks, the stock has recorded a low of ₹132.50 and a high of ₹231.85. In terms of performance, Piramal Pharma Ltd share price has increased by 54.05% over the past six months and has increased by 9.65% over the last year.
PPLPHARMA Stock Price Chart
Piramal Pharma Ltd Overview
Market cap₹27,985 Crs
Volume2,15,955
Prev. Close₹208.15
Year range₹132.50 - ₹231.85
ISININE0DK501011
About PPLPHARMA
Piramal Pharma perates as a pharmaceutical company. The Company manufactures and develops a wide range of pharmaceutical solutions to reduce diseases.
Piramal Pharma Ltd Historical Performance
1 Month Return1.33%
6 Month Return48.97%
3 Year Return116.81%
3 Month Return25.38%
1 Year Return7.68%
5 Year Return-
Piramal Pharma Ltd Fundamentals
ROCE(TTM)11.75%
P/E Ratio (TTM)39.96
P/B Ratio3.44
Debt to Equity0.10
ROE9.51%
EPS (TTM)5.82
Dividend Yield0.00%
Book Value61.18
Profit Margin15.69%
Operating Margin9.17%
Piramal Pharma Ltd Financials
| Indicator | Mar 26 | Mar 25 | Mar 24 | Mar 23 | Mar 22 |
|---|---|---|---|---|---|
| Revenue | 5,444.74 | 5,493.06 | 4,592.17 | 3,784.29 | 3,565.21 |
| EBITDA | 1,212.22 | 1,247.79 | 819.98 | 431.64 | 684.99 |
| Net Profit | 700.01 | 691.40 | 391.22 | 69.50 | 367.54 |
| EPS | 5.28 | 5.22 | 3.05 | 0.58 | 3.12 |
Piramal Pharma Ltd Technical Analysis
| Indicator | Value |
|---|---|
| Support 1 (S1) | 205.30 |
| Resistance 1 (R1) | 212.90 |
| Pivot Point | 210.05 |
Piramal Pharma Ltd Dividend History
| Ex Date | Dividends Date | Record Date | Dividend Type | Dividend Details |
|---|---|---|---|---|
| 16-Jul-2025 | 14-May-2025 | 16-Jul-2025 | Final | ₹0.14 |
| 12-Jul-2024 | 10-May-2024 | 12-Jul-2024 | Final | ₹0.11 |
PPLPHARMA Key Leadership Details
Last Updated: Mar 2026
| Name | Position |
|---|---|
| Nandini Piramal | Chairperson / Executive Directorector |
| PETER D DEYOUNG | Chief Executive Officer |
| Vivek Valsaraj | Chief Financial Officer |
Piramal Pharma Ltd Peer Comparison
| Company | Price | M.Cap (Cr) | P/E (TTM) | ROE (TTM) |
|---|---|---|---|---|
| Sun Pharmaceutical Industries LtdSUNPHARMA | ₹1,852.20+0.12% | ₹4,19,727.66 | 38.32 | 13.74% |
| Divis Laboratories LtdDIVISLAB | ₹9,619.50+0.18% | ₹1,67,235.91 | 67.46 | 15.32% |
| Torrent Pharmaceuticals LtdTORNTPHARM | ₹4,988.50+1.22% | ₹1,46,951.32 | 64.68 | 25.49% |
Disclaimer
The information provided on this page is for informational purposes only and should not be construed as investment advice, recommendation, or solicitation to buy or sell any securities or financial pr...
Frequently Asked Questions
- The share price of Piramal Pharma Ltd today is ₹210.20 on NSE and ₹210.20 on BSE.
- The 52-week high of Piramal Pharma Ltd is ₹231.85, while the 52-week low is ₹132.50.
- The current market capitalisation of Piramal Pharma Ltd is approximately ₹27,985 crore.
- The P/E (Price-to-Earnings) ratio of Piramal Pharma Ltd is -124.47. The ratio may vary with changes in the share price and earnings.
- The P/B (Price-to-Book) ratio of Piramal Pharma Ltd is 2.52. It compares the company’s market value with its book value and can provide an indication of how the market values the company relative to its net assets.
- To buy Piramal Pharma Ltd shares, you first need to open a demat account before you can place an order. Here's the process:
• Open a demat account online using your PAN, Aadhaar and bank details.
• Add funds to your trading account via UPI or net banking.
• Search for PPLPHARMA on TradeMobi or the Anand Rathi web platform.
• Place your order
• Track your holdings in the portfolio section. - Over the past 3 years, Piramal Pharma Ltd has delivered a return of approximately 116.81%. This return is based on the change in the share price over the specified period and may differ depending on the measurement date. Past performance does not guarantee future returns.
- The shareholding pattern of Piramal Pharma Ltd comprises different categories of shareholders. As of Jun 2026, the shareholding is approximately 34.80% promoters, -0.67% FIIs, 14.57% DIIs, and 14.54% public shareholders.
Download TradeMobi App
- Real-Time Market Data
- Advanced Trading Tools
- Expert-Backed Research
